EpiBiome
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
EpiBiome - overview
Location
San Francisco, CA, US
Primary Industry
Biotechnology
About
EpiBiome is a data management firm that provides advanced solutions to enhance operational efficiency and data accessibility for businesses across various sectors, including finance and healthcare. EpiBiome specializes in advanced data management solutions. Founded by Aaron Hammack, the company is located in San Francisco, US. It raised USD 1.
00 mn in a VENTURE DEBT round led by Silicon Valley Bank on June 23, 2016, bringing its total amount raised to USD 6. 00 mn. The company specializes in advanced data management solutions that streamline client operations and enhance data accessibility. Its core products include a robust database management system that integrates with existing IT infrastructures, facilitating efficient storage, retrieval, and analysis of large data volumes.
EpiBiome's solutions optimize business intelligence processes, provide real-time analytics, and improve decision-making for clients in finance, healthcare, and retail, as well as small to medium-sized businesses. The company's products are marketed primarily in North America and Europe, focusing on technology-driven urban centers. EpiBiome generates revenue through a subscription-based service model, allowing clients to access database management solutions on a recurring basis via annual contracts with tiered pricing based on usage and features. In addition to subscriptions, the company earns revenue through partnerships with technology integrators and resellers that distribute their products to end-users, fostering long-term engagements to maximize utility and ensure stable revenue streams.
EpiBiome plans to design and launch new products to enhance its service offerings, with specific release dates yet to be confirmed. The company targets expansion into additional geographic markets within North America and Europe by leveraging its recent funding, which will be utilized to support these initiatives. The latest funding of USD 1. 00 mn, raised in June 2016, will help facilitate these growth strategies.
Current Investors
Silicon Valley Bank, Matrix Partners, Alexandria Venture Investments
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.epibiome.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
EpiBiome - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.